Search research articles
Contact Us
Filters
Showing results (501-510 of 794) with videos related to
Page
of 80
Sort By:
Clinical Endocrinology
|
January 17, 2004
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion
P V Carroll, J P Monson, A B Grossman, et al.
Hormone Research
|
September 30, 2005
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease
J E Greening, C E Brain, L A Perry, et al.
Journal of Neuroendocrinology
|
August 12, 1999
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants
M Korbonits, J A Little, M L Forsling, et al.
British Journal of Anaesthesia
|
June 12, 1999
Dissociation of pituitary-adrenal and catecholamine activation after induced cardiac arrest and defibrillation
M J O'Leary, A C Timmins, J N Appleby, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors
M Korbonits, S A Bustin, M Kojima, et al.
Nuclear Medicine Communications
|
March 4, 2003
123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases
A Signore, A Picarelli, A Annovazzi, et al.
European Journal of Endocrinology
|
November 1, 1996
L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide
M Korbonits, P J Trainer, G Fanciulli, et al.
Clinical Endocrinology
|
January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients
Amar Agha, Dorothy Walker, Les Perry, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma
Anthony P Goldstone, Michael Patterson, Nila Kalingag, et al.
Clinical Endocrinology
|
December 1, 1996
Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution
M Korbonits, P J Trainer, M L Nelson, et al.
Page
of 80
Search research articles
Search
Showing results (501-510 of 794) with videos related to
Sort By:
Page
of 80
Clinical Endocrinology
|
January 17, 2004
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion
P V Carroll, J P Monson, A B Grossman, et al.
Hormone Research
|
September 30, 2005
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease
J E Greening, C E Brain, L A Perry, et al.
Journal of Neuroendocrinology
|
August 12, 1999
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants
M Korbonits, J A Little, M L Forsling, et al.
British Journal of Anaesthesia
|
June 12, 1999
Dissociation of pituitary-adrenal and catecholamine activation after induced cardiac arrest and defibrillation
M J O'Leary, A C Timmins, J N Appleby, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 7, 2001
The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors
M Korbonits, S A Bustin, M Kojima, et al.
Nuclear Medicine Communications
|
March 4, 2003
123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases
A Signore, A Picarelli, A Annovazzi, et al.
European Journal of Endocrinology
|
November 1, 1996
L-arginine is unlikely to exert neuroendocrine effects in humans via the generation of nitric oxide
M Korbonits, P J Trainer, G Fanciulli, et al.
Clinical Endocrinology
|
January 5, 2007
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients
Amar Agha, Dorothy Walker, Les Perry, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 3, 2005
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma
Anthony P Goldstone, Michael Patterson, Nila Kalingag, et al.
Clinical Endocrinology
|
December 1, 1996
Differential stimulation of cortisol and dehydroepiandrosterone levels by food in obese and normal subjects: relation to body fat distribution
M Korbonits, P J Trainer, M L Nelson, et al.
Page
of 80